RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

Stock Information for RxSight Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About RxSight Inc.

RxSight, Inc. to Present at the Bank of America Healthcare Conference
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.